VEEV vs. ADMA
VEEV (Veeva Systems Inc.) and ADMA (ADMA Biologics, Inc.) are both stocks. Both are in the Healthcare sector — VEEV in Health Information Services, ADMA in Biotechnology. Over the past 10 years, VEEV returned 16.73%/yr vs 1.84%/yr for ADMA. At a 0.17 correlation, their price movements are largely independent.
Performance
VEEV vs. ADMA - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, VEEV achieves a -28.53% return, which is significantly higher than ADMA's -54.99% return. Over the past 10 years, VEEV has outperformed ADMA with an annualized return of 16.73%, while ADMA has yielded a comparatively lower 1.84% annualized return.
VEEV
- 1D
- -1.24%
- 1M
- 2.45%
- YTD
- -28.53%
- 6M
- -28.54%
- 1Y
- -43.46%
- 3Y*
- -5.80%
- 5Y*
- -11.82%
- 10Y*
- 16.73%
ADMA
- 1D
- -1.32%
- 1M
- -3.41%
- YTD
- -54.99%
- 6M
- -58.49%
- 1Y
- -61.99%
- 3Y*
- 27.09%
- 5Y*
- 35.16%
- 10Y*
- 1.84%
VEEV vs. ADMA - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
VEEV Veeva Systems Inc. | -28.53% | 6.17% | 9.21% | 19.30% | -36.83% | -6.16% | 93.55% | 57.48% | 61.58% | 35.82% |
ADMA ADMA Biologics, Inc. | -54.99% | 6.36% | 279.42% | 16.49% | 175.18% | -27.69% | -51.25% | 67.36% | -25.55% | -37.30% |
Correlation
The correlation between VEEV and ADMA is 0.12, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.12 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.24 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.27 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.19 |
Correlation (All Time) Calculated using the full available price history since Oct 17, 2013 | 0.17 |
The correlation between VEEV and ADMA shifts across timeframes, from 0.12 (1 year) to 0.27 (5 years), reflecting how their relationship changes across market environments.
Fundamentals
VEEV:
$26.48B
ADMA:
$1.97B
VEEV:
$5.63
ADMA:
$0.68
VEEV:
28.36
ADMA:
12.13
VEEV:
8.04
ADMA:
3.93
VEEV:
3.63
ADMA:
5.05
VEEV:
$3.32B
ADMA:
$509.86M
VEEV:
$2.49B
ADMA:
$312.42M
VEEV:
$1.00B
ADMA:
$218.74M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
VEEV vs. ADMA — Risk / Return Rank
VEEV
ADMA
VEEV vs. ADMA - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Veeva Systems Inc. (VEEV) and ADMA Biologics, Inc. (ADMA). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| VEEV | ADMA | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -0.08 | ||
| Sortino ratioReturn per unit of downside risk | -0.07 | ||
| Omega ratioGain probability vs. loss probability | 0.77 | 0.76 | +0.01 |
| Calmar ratioReturn relative to maximum drawdown | -0.86 | -0.98 | +0.12 |
| Martin ratioReturn relative to average drawdown | -1.51 | -1.95 | +0.43 |
Loading charts...
Drawdowns
VEEV vs. ADMA - Drawdown Comparison
The maximum VEEV drawdown since its inception was -61.35%, smaller than the maximum ADMA drawdown of -91.28%. Use the drawdown chart below to compare losses from any high point for VEEV and ADMA.
Loading charts...
Drawdown Indicators
| VEEV | ADMA | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -61.35% | -91.28% | +29.93% |
Max Drawdown (1Y)Largest decline over 1 year | -50.55% | -63.48% | +12.93% |
Max Drawdown (3Y)Largest decline over 3 years | -50.55% | -68.99% | +18.44% |
Max Drawdown (5Y)Largest decline over 5 years | -55.69% | -68.99% | +13.30% |
Max Drawdown (10Y)Largest decline over 10 years | -55.69% | -86.11% | +30.42% |
Current DrawdownCurrent decline from peak | -53.21% | -66.50% | +13.29% |
Average DrawdownAverage peak-to-trough decline | -26.08% | -53.05% | +26.97% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 28.76% | 33.85% | -5.09% |
Volatility
VEEV vs. ADMA - Volatility Comparison
Veeva Systems Inc. (VEEV) has a higher volatility of 14.08% compared to ADMA Biologics, Inc. (ADMA) at 9.74%. This indicates that VEEV's price experiences larger fluctuations and is considered to be riskier than ADMA based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| VEEV | ADMA | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.08% | 9.74% | +4.34% |
Volatility (6M)Calculated over the trailing 6-month period | 29.27% | 45.54% | -16.27% |
Volatility (1Y)Calculated over the trailing 1-year period | 35.87% | 54.60% | -18.73% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 37.98% | 59.47% | -21.49% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 38.23% | 69.03% | -30.80% |
Dividends
VEEV vs. ADMA - Dividend Comparison
Neither VEEV nor ADMA has paid dividends to shareholders.
Financials
VEEV vs. ADMA - Financials Comparison
This section allows you to compare key financial metrics between Veeva Systems Inc. and ADMA Biologics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
VEEV vs. ADMA - Profitability Comparison
VEEV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Veeva Systems Inc. reported a gross profit of 659.69M and revenue of 882.95M. Therefore, the gross margin over that period was 74.7%.
ADMA - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a gross profit of 80.75M and revenue of 114.49M. Therefore, the gross margin over that period was 70.5%.
VEEV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Veeva Systems Inc. reported an operating income of 273.11M and revenue of 882.95M, resulting in an operating margin of 30.9%.
ADMA - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported an operating income of 58.27M and revenue of 114.49M, resulting in an operating margin of 50.9%.
VEEV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Veeva Systems Inc. reported a net income of 260.94M and revenue of 882.95M, resulting in a net margin of 29.6%.
ADMA - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, ADMA Biologics, Inc. reported a net income of 45.33M and revenue of 114.49M, resulting in a net margin of 39.6%.
Frequently Asked Questions
VEEV and ADMA have a correlation of 0.12, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
VEEV has higher volatility (14.08%) compared to ADMA (9.74%). In terms of maximum drawdown, VEEV dropped -61.35% vs ADMA's -91.28%.
ADMA currently has the higher Sharpe Ratio (-1.14 vs -1.22), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for VEEV and ADMA
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer